Outcome of Board Meeting held on May 8, 2026
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.1 pts more than Nifty Microcap 250 and 5.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Artemis Medicare Services reported audited standalone PAT of Rs 10,344.15 Lacs for FY26, up 23.9% from Rs 8,345.78 Lacs in FY25. Consolidated PAT stood at Rs 10,371.52 Lacs, up 26.2% from Rs 8,217.62 Lacs. Revenue from operations grew to Rs 1,06,049.17 Lacs (standalone) and Rs 1,08,124.24 Lacs (consolidated). The Board recommended a final dividend of Rs 0.45 per share (45% on face value of Rs 1). An exceptional item of Rs 307.44 Lacs was recognized due to the implementation of new Labour Codes. The auditors issued an unmodified (clean) opinion. The Board also approved appointment of Mr. Tapan Mitra as Additional Independent Director and extension of utilization period for preferential issue funds by 18 months.
Strong profitability growth with PAT up over 24% demonstrates operational efficiency improvement. The clean audit opinion and dividend recommendation are positive signals for shareholders. The Labour Code exceptional item is non-recurring and should not impact recurring earnings assessment.